4.6 Article

Can Concurrent Abnormalities in Free Light Chains and Immunoglobulin Concentrations Identify a Target Population for Immunoglobulin Trials in Sepsis?

Journal

CRITICAL CARE MEDICINE
Volume 45, Issue 11, Pages 1829-1836

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CCM.0000000000002627

Keywords

immunoglobulin kappa light chain; immunoglobulin lambda light chain; prognosis; sepsis

Funding

  1. ICU research funds at Guy's and St Thomas' National Health Service (NHS) Foundation Trust
  2. National Institute For Health Research (NIHR) Biomedical Research Centre at Kings Health Partners, London, United Kingdom
  3. U.K. National Institute for Health Research Clinician Scientist Award [NIHR-CS-2016-16-011]
  4. BioTest
  5. U.K. National Institute for Health Research Senior Investigator Award
  6. National Institute for Health Research [CS-2016-16-011, 16/33/01] Funding Source: researchfish

Ask authors/readers for more resources

Objectives: Light chains kappa and lambda are immunoglobulin constituents but also circulate independently in blood as free light chains. We investigated whether a concomitant abnormality in free light chain and immunoglobulin levels could identify a high risk of death sepsis subpopulation to inform future IV immunoglobulin trials. We tested whether light chain allelic inclusion occurs in circulating B cells. Design: Prospective cohort study. Setting: Adult general ICUs. Patients: Adult sepsis patients without any documented immune comorbidity. Interventions: None. Measurements and Main Results: Serum total free light chain, immunoglobulin G, immunoglobulin A, and immunoglobulin M were measured on ICU days 1, 3, and 7. Population normal ranges defined normal and abnormal categories. Logistic regression models tested any independent relationship between high free light chain, immunoglobulins and hospital mortality. CD19 B-cell subsets expressing cell surface kappa and lambda were quantified by flow cytometry; their frequencies were compared against healthy subjects and correlation assessed against free light chain concentrations. On ICU day 1, high free light chain lambda and high free light chain kappa were seen in 46.5% and 75.3% of the study cohort (n = 101). Low immunoglobulin levels were commonplace (45.5%) at ICU admission. ICU admission day free light chain and immunoglobulin concentrations were significantly correlated. Septic patients had significantly more CD19 B cells expressing both kappa and lambda compared with healthy controls (median [interquartile range] 4.1% [2.4-11.0] vs 1.3% [1.2-2.9], respectively; p = 0.0001); these correlated with free light chain concentrations. Conclusions: To our knowledge, abnormalities and associations of free light chain in critically ill adults with sepsis have not been previously reported. The additional prognostic value of free light chain lambda and the significance of allelic inclusion in B cells in sepsis require further investigation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available